You're right, silly of me for missing that! That makes the potential upside of just Vitiligo and EPP alone even more exciting, especially given that the expected penetration is very conservative due to the lack of alternative options for people suffering with Vitiligo. The share price would be well over $200 even at a reasonable multiple. However, we do know how the market likes to give these high margin, high growth, healthcare stocks very high multiples. I left out the cosmetic opportunity because it is too hard to predict as we don't yet know pricing etc. I do think that will come to be the biggest segment though, and so I think Clinuvel will need to end up doing a share split or the share price numbers will start to be silly high!
CUV Price at posting:
$11.90 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)